CoChat

Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes

Open access

The DOI matches its Crossref record; 180 of the 182 references it cites were found in a registry or an index; 67 of the 185 sources its claims cite were checked for support.

Abstract

The Ehlers‒Danlos syndromes (EDS) constitute a heterogenous group of connective tissue disorders characterized by joint hypermobility, skin abnormalities, and vascular fragility. The latest nosology recognizes 13 types caused by pathogenic variants in genes encoding collagens and other molecules involved in collagen processing and extracellular matrix (ECM) biology. Classical (cEDS), vascular (vEDS), and hypermobile (hEDS) EDS are the most frequent types. cEDS and vEDS are caused respectively by defects in collagen V and collagen III, whereas the molecular basis of hEDS is unknown. For these disorders, the molecular pathology remains poorly studied. Herein, we review, expand, and compare our previous transcriptome and protein studies on dermal fibroblasts from cEDS, vEDS, and hEDS patients, offering insights and perspectives in their molecular mechanisms. These cells, though sharing a pathological ECM remodeling, show differences in the underlying pathomechanisms. In cEDS and vEDS fibroblasts, key processes such as collagen biosynthesis/processing, protein folding quality control, endoplasmic reticulum homeostasis, autophagy, and wound healing are perturbed. In hEDS cells, gene expression changes related to cell-matrix interactions, inflammatory/pain responses, and acquisition of an in vitro pro-inflammatory myofibroblast-like phenotype may contribute to the complex pathogenesis of the disorder. Finally, emerging findings from miRNA profiling of hEDS fibroblasts are discussed to add some novel biological aspects about hEDS etiopathogenesis.

Overview

CoChat Summary

TL;DR

This review compares transcriptome and protein findings from dermal fibroblasts of patients with classical, vascular, and hypermobile Ehlers‒Danlos syndromes, highlighting shared ECM disarray but distinct pathomechanisms. cEDS and vEDS are linked to collagen V and III defects with perturbed collagen processing, ER homeostasis, autophagy, and wound healing, whereas hEDS/HSD shows cell-matrix, inflammatory/pain, and pro-inflammatory myofibroblast-like changes without a known molecular basis.

Key findings

  • The 2017 nosology recognizes 13 EDS subtypes caused by pathogenic variants in 19 genes; cEDS, vEDS, and hEDS account for more than 90% of patients.
  • cEDS and vEDS fibroblasts show perturbed collagen biosynthesis/processing, protein folding quality control, ER homeostasis, autophagy, and wound healing; hEDS/HSD cells show altered cell-matrix interactions, inflammatory/pain responses, and an in vitro pro-inflammatory myofibroblast-like phenotype.
  • All three cell types share pathological ECM remodeling, but their underlying transcriptional patterns differ, supporting distinct disease mechanisms.
  • miRNA profiling of hEDS/HSD fibroblasts identified 19 dysregulated miRNAs, including the most overexpressed miR-378-3p, up-regulated miRNA-224, and reduced miRNA-23a.

Methods

  • Narrative review that expands and compares the authors’ previous transcriptome and protein studies on dermal fibroblasts from cEDS, vEDS, and hEDS/HSD patients.
  • Data include differential gene expression, ECM protein organization, ER/autophagy markers, inflammatory and myofibroblast-related pathways, and miRNA profiling from patient-derived fibroblasts.
  • Main analysis is a comparative synthesis of molecular mechanisms across EDS types; proteome profiling of hEDS/HSD cells is described as currently ongoing.

Limitations

  • The paper states that the molecular pathology of these disorders remains poorly studied, the molecular basis of hEDS is unknown, and no validated biological biomarkers have been identified for hEDS/HSD.
  • The paper states that additional functional work is needed to establish the involvement of specific proteins and pathways, and that further studies are warranted for ER perturbation in vEDS.
  • Evident from the text: this is a narrative review relying largely on prior in vitro fibroblast studies, without a described systematic search or meta-analysis, so findings may not fully reflect in vivo disease mechanisms.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/genes10080609

Cites

180 of 180 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Schematic illustration summarizing the processes likely involved in the pathogenesis of cEDS, vEDS, and hEDS/HSD derived from transcriptome and in vitro studies of patients’ skin fibroblasts.
Figure 1 Schematic illustration summarizing the processes likely involved in the pathogenesis of cEDS, vEDS, and hEDS/HSD derived from transcriptome and in vitro studies of patients’ skin fibroblasts.CC BY · PubMed Central

Verification

Claims the paper makes

28 Valid · 1 Not valid · 66 Not checked · 33 Own results and interpretations

81 more claims · 15 with their cited sources checked

Create a free account to see all 128 claims and to verify the 118 references still open.

See all claims — free account
  • It may state two separate claims as one. 30
  • Probably not a substantial claim. 16

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 1

  1. Jacobs, J.W.G., and Cornelissens, L.J.M. (2018). Genetics and testing of Ehlers-Danlos syndrome and of differential diagnostic diseases. Ehlers-Danlos Syndrome: A Multidisciplinary Approach, IOS Press BV. [1st ed.]. Chapter 3.

Cited by

See all 88

Metadata

Authors
Chiarelli, N., Ritelli, M., Zoppi, N., & Colombi, M.
Affiliations
University of Brescia (IT)
Corresponding author
Colombi, Marina
Venue
Genes
Publisher
MDPI AG
Published
2019-08-12
Volume
10
Issue
8
Pages
609
ISSN
2073-4425 (ISSN-L)
OpenAlex
W2968654896
Cited by
82
References
182
Citations by year
2026: 7 · 2025: 13 · 2024: 15 · 2023: 10 · 2022: 15 · 2021: 12 · 2020: 9 · 2019: 1
FWCI
1.24
Type
journal article
Language
en
Open access
Locations
  • Genes (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion, other-oa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Dermatological and Skeletal Disorders
  • Health Sciences › Dentistry › Periodontics › Oral and gingival health research
Keywords
Ehlers-Danlos syndrome, classical Ehlers-Danlos syndrome, vascular Ehlers-Danlos syndrome, hypermobile Ehlers-Danlos syndrome, connective tissue diseases, dermal fibroblasts, type V collagen, type III collagen, extracellular matrix remodeling, collagen synthesis, protein folding quality control, endoplasmic reticulum homeostasis, autophagy, wound healing, cell-matrix interactions, inflammation, pain, miRNA expression profiling, pathogenesis
MeSH terms
Animals, Autophagy, Ehlers-Danlos Syndrome, Extracellular Matrix, Fibroblasts, Humans, Wound Healing, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.